Ichiro Naruse
Takasaki, 3700001, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 12, 2022
Predictive significance of circulating tumor DNA against patients with T790M-positive EGFR-mutant NSCLC receiving osimertinib.
Journal: Scientific reports
Published: April 03, 2022
Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer.
Journal: Scientific reports
Published: March 26, 2022
Interstitial lung disease secondary to alectinib after interstitial injury induced by crizotinib.
Journal: Journal of cancer research and therapeutics
Published: September 15, 2020
Efficacy and safety of S-1 monotherapy in previously treated elderly patients (aged ≥75 years) with non-small cell lung cancer: A retrospective analysis.
Journal: Thoracic cancer
Published: June 04, 2020
Glasgow prognostic score predicts efficacy and prognosis in patients with advanced non-small cell lung cancer receiving EGFR-TKI treatment.
Journal: Thoracic cancer
Published: April 13, 2020
Occurrence of Hematological Malignancy in Long-term Survivors With Advanced Thymic Cancer.
Journal: In vivo (Athens, Greece)
Published: February 15, 2020
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
Journal: Cancer chemotherapy and pharmacology
Published: December 03, 2019
Occurrence of Ventricular Fibrillation in a Patient With Lung Cancer Receiving Osimertinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 27, 2019
Administration of docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte colony-stimulating factor for pretreated non-small cell lung cancer: a phase II study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 07, 2019
Last Updated: 09/26/2026